University of Pennsylvania
Philadelphia, Pennsylvania, United States
Purpose
to test novel SOSIP and SHIV combinations for their ability to elicit broadly neutralizing antibodies in rhesus macaques as a “molecular guide” to inform and accelerate HIV/AIDS vaccine development in humans
Division
Global Health
Date
March 2019
Region Served
GLOBAL
Committed amount
$6,399,726
Grant topic
HIV
Duration (months)
36
Grantee location
Philadelphia, Pennsylvania, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.